1. Home
  2. SNT vs VNRX Comparison

SNT vs VNRX Comparison

Compare SNT & VNRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Senstar Technologies Ltd.

SNT

Senstar Technologies Ltd.

N/A

Current Price

$2.95

Market Cap

87.5M

ML Signal

N/A

Logo VolitionRX Limited

VNRX

VolitionRX Limited

HOLD

Current Price

$0.17

Market Cap

31.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SNT
VNRX
Founded
1965
N/A
Country
Canada
United States
Employees
N/A
N/A
Industry
Telecommunications Equipment
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Sector
Telecommunications
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
87.5M
31.9M
IPO Year
2023
2012

Fundamental Metrics

Financial Performance
Metric
SNT
VNRX
Price
$2.95
$0.17
Analyst Decision
Strong Buy
Analyst Count
0
5
Target Price
N/A
$2.13
AVG Volume (30 Days)
18.6K
15.1M
Earning Date
04-22-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
38.00
EPS
N/A
N/A
Revenue
N/A
$1,727,384.00
Revenue This Year
N/A
$479.89
Revenue Next Year
N/A
$536.25
P/E Ratio
$19.22
N/A
Revenue Growth
N/A
40.04
52 Week Low
$2.57
$0.17
52 Week High
$5.34
$0.94

Technical Indicators

Market Signals
Indicator
SNT
VNRX
Relative Strength Index (RSI) 41.16 38.02
Support Level $2.75 $0.17
Resistance Level $3.16 $0.32
Average True Range (ATR) 0.16 0.03
MACD 0.03 0.00
Stochastic Oscillator 32.65 1.13

Price Performance

Historical Comparison
SNT
VNRX

About SNT Senstar Technologies Ltd.

Senstar Technologies Corp is a provider of comprehensive physical, video, and access control security products and solutions. Its perimeter intrusion detection systems (including fence sensors, buried sensors, and above-ground sensors), intelligent video management, video analytics, and access control offer a comprehensive suite of integrated solutions that reduce complexity, improve performance, and unify support.

About VNRX VolitionRX Limited

VolitionRX Ltd is a United States-based epigenetics company that applies its Nucleosomics platform through its subsidiaries to develop simple, easy-to-use, cost-effective blood tests to help diagnose and monitor range of life-altering diseases including some cancers and diseases associated with NETosis such as sepsis and COVID-19. The tests are based on the science of Nucleosomics, which is the practice of identifying and measuring nucleosomes in the bloodstream or other bodily fluid - an indication that disease is present. The company is focused on human diagnostics and monitoring but also has a subsidiary focused on animal diagnostics and monitoring.

Share on Social Networks: